Q2 2026 saw over 10% revenue growth and a 19% rise in adjusted EPS, driven by strong demand across all channels and operational improvements. Full-year guidance was raised, with robust performance in advanced diagnostics and stable financial metrics.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.